INVO Fertility, Inc. (IVF) - Net Assets

Latest as of September 2025: $5.85 Million USD

Based on the latest financial reports, INVO Fertility, Inc. (IVF) has net assets worth $5.85 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($18.83 Million) and total liabilities ($12.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read INVO Fertility, Inc. total liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$5.85 Million
% of Total Assets	31.06%
Annual Growth Rate	38.23%
5-Year Change	121.96%
10-Year Change	N/A
Growth Volatility	656.31

INVO Fertility, Inc. - Net Assets Trend (2006–2024)

This chart illustrates how INVO Fertility, Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore INVO Fertility, Inc. assets under control for the complete picture of this company's asset base.

Annual Net Assets for INVO Fertility, Inc. (2006–2024)

The table below shows the annual net assets of INVO Fertility, Inc. from 2006 to 2024. For live valuation and market cap data, see market value of INVO Fertility, Inc..

Year	Net Assets	Change
2024-12-31	$12.75 Million	+1328.13%
2023-12-31	$892.60K	+191.30%
2022-12-31	$-977.61K	-113.37%
2021-12-31	$7.31 Million	+27.29%
2020-12-31	$5.74 Million	+254.65%
2019-12-31	$-3.71 Million	-36.32%
2018-12-31	$-2.72 Million	+45.43%
2017-12-31	$-4.99 Million	-8.11%
2016-12-31	$-4.62 Million	-22.91%
2015-12-31	$-3.76 Million	+13.81%
2014-12-31	$-4.36 Million	-14.26%
2013-12-31	$-3.81 Million	-13.11%
2012-12-31	$-3.37 Million	-15.30%
2011-12-31	$-2.93 Million	-17.86%
2010-12-31	$-2.48 Million	+19.47%
2009-12-31	$-3.08 Million	-1260.36%
2008-12-31	$-226.57K	-124.49%
2007-12-31	$-100.93K	-368.86%
2006-12-31	$37.54K	--

Equity Component Analysis

This analysis shows how different components contribute to INVO Fertility, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6715643200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	$37.00	0.00%
Other Components	$79.91 Million	626.89%
Total Equity	$12.75 Million	100.00%

INVO Fertility, Inc. Competitors by Market Cap

The table below lists competitors of INVO Fertility, Inc. ranked by their market capitalization.

Company	Market Cap
Inbest Prime III Inmuebles SOCIMI S.A. MC:YINB3	$13.23 Million
EUDA Health Holdings Limited NASDAQ:EUDA	$13.23 Million
Cardiex Ltd AU:CDX	$13.23 Million
PT Jaya Bersama Indo Tbk JK:DUCK	$13.23 Million
Origin Agritech Ltd NASDAQ:SEED	$13.22 Million
Indiana Resources Ltd AU:IDA	$13.22 Million
Ornapaper Bhd KLSE:5065	$13.22 Million
NextCell Pharma AB ST:NXTCL	$13.21 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in INVO Fertility, Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 892,825 to 12,747,473, a change of 11,854,648 (1327.8%).
Net loss of 9,095,838 reduced equity.
New share issuances of 1,809,035 increased equity.
Other factors increased equity by 19,141,451.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	$-9.10 Million	-71.35%
Share Issuances	$1.81 Million	+14.19%
Other Changes	$19.14 Million	+150.16%
Total Change	$-	1327.77%

Book Value vs Market Value Analysis

This analysis compares INVO Fertility, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.01x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.80x to 0.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-12-31	$2.37	$1.90	x
2007-12-31	$-4.55	$1.90	x
2008-12-31	$-1.20	$1.90	x
2009-12-31	$-10.92	$1.90	x
2010-12-31	$-7.58	$1.90	x
2011-12-31	$-6.83	$1.90	x
2012-12-31	$-7.87	$1.90	x
2013-12-31	$-8.91	$1.90	x
2014-12-31	$-10.18	$1.90	x
2015-12-31	$-5.32	$1.90	x
2016-12-31	$-6.37	$1.90	x
2017-12-31	$-6.81	$1.90	x
2018-12-31	$-3.42	$1.90	x
2019-12-31	$-4.61	$1.90	x
2020-12-31	$6.34	$1.90	x
2021-12-31	$1200.74	$1.90	x
2022-12-31	$-140.80	$1.90	x
2023-12-31	$54.45	$1.90	x
2024-12-31	$299.52	$1.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently INVO Fertility, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -71.35%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -139.25%
• Asset Turnover: 0.14x
• Equity Multiplier: 3.64x
Recent ROE (-71.35%) is below the historical average (-64.60%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	-19.68%	0.00%	0.00x	1.01x	$-11.14K
2007	0.00%	0.00%	0.00x	0.00x	$-204.00K
2008	0.00%	-4930.66%	0.05x	0.00x	$-1.85 Million
2009	0.00%	-7375.39%	0.14x	0.00x	$-4.35 Million
2010	0.00%	-226.81%	0.37x	0.00x	$94.76K
2011	0.00%	-1115.30%	0.56x	0.00x	$-504.94K
2012	0.00%	-1182.14%	0.45x	0.00x	$-329.18K
2013	0.00%	-2810.77%	0.22x	0.00x	$-379.20K
2014	0.00%	-10444.13%	0.15x	0.00x	$-1.30 Million
2015	0.00%	-42426.61%	0.02x	0.00x	$-4.58 Million
2016	0.00%	-4173.30%	0.18x	0.00x	$-1.66 Million
2017	0.00%	-248.87%	1.06x	0.00x	$-202.95K
2018	0.00%	-622.22%	0.64x	0.00x	$-2.80 Million
2019	0.00%	-146.43%	0.82x	0.00x	$-1.80 Million
2020	-145.34%	-804.73%	0.09x	1.91x	$-8.92 Million
2021	-91.03%	-159.97%	0.40x	1.43x	$-7.39 Million
2022	0.00%	-1324.81%	0.22x	0.00x	$-10.79 Million
2023	-899.91%	-266.00%	0.16x	20.73x	$-8.12 Million
2024	-71.35%	-139.25%	0.14x	3.64x	$-10.37 Million

Industry Comparison

This section compares INVO Fertility, Inc.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $2,432,799,891
Average return on equity (ROE) among peers: -74.29%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
INVO Fertility, Inc. (IVF)	$5.85 Million	-19.68%	2.22x	$13.23 Million
Abbott Laboratories (ABT)	$24.16 Billion	9.46%	0.81x	$155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM)	$-13.54K	0.00%	0.00x	$21.60 Million
Aethlon Medical Inc (AEMD)	$9.29 Million	-84.45%	0.15x	$2.79 Million
Acutus Medical Inc (AFIB)	$105.73 Million	-116.68%	0.61x	$903.35K
Adapthealth Corp (AHCO)	$15.14 Million	-140.98%	14.05x	$1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX)	$2.15 Million	-112.84%	0.45x	$16.04 Million
Allurion Technologies, Inc. (ALUR)	$-70.49 Million	0.00%	0.00x	$8.60 Million
Autonomix Medical, Inc. Common Stock (AMIX)	$644.00K	-309.01%	0.34x	$4.22 Million
Artivion Inc (AORT)	$89.39 Million	8.74%	0.25x	$1.73 Billion
Apyx Medical Inc (APYX)	$21.15 Million	2.82%	0.30x	$125.55 Million

About INVO Fertility, Inc.

NASDAQ:IVF USA Medical Devices

Market Cap

$13.23 Million

Market Cap Rank

#26180 Global

#5235 in USA

Share Price

$1.90

Change (1 day)

+1.06%

52-Week Range

$0.25 - $3.46

All Time High

$3.46